Dr. Peyton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
103 Physicians Way
Suite 120
Lebanon, TN 37090Phone+1 615-453-5623Fax+1 615-453-8592
Education & Training
University of TennesseeFellowship, Hematology and Medical Oncology, 2001 - 2003- University of TennesseeResidency, Internal Medicine, 1998 - 2001
University of Tennessee Health Science Center College of MedicineClass of 1998
Certifications & Licensure
TN State Medical License 2000 - 2025- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 61 citationsBevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.John D. Hainsworth, Jeffrey R. Infante, David R. Spigel, James D. Peyton, Dana S. Thompson
Cancer. 2010-09-01 - 39 citationsA Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER TrialAndrew H. Ko, Patrick B. Murphy, James D. Peyton, Dianna Shipley, Ahmed Al-Hazzouri
The Oncologist. 2017-12-01 - 5 citationsRegorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety...Andrew S. Kennedy, Dianna Shipley, Max Shpak, Laura Blakely, Brian Hemphill
Frontiers in Oncology. 2019-07-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
